Skip to content
Screener

Innoviva, Inc. INVA Investing Cash Flow

Investing Cash Flow at other companies

Pfizer logo
PfizerPFE
$785M-76.0%
Merck & Co. logo
Merck & Co.MRK
-$5.6B-628%
AbbVie logo
AbbVieABBV
-$574M+21.9%
Insmed logo
InsmedINSM
$24.51M-89.2%
Savara logo
SavaraSVRA
$32.6M+34.0%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$3.58M-90.3%

Other financials

Income statement

See full
Revenue$119.6M+19.3%
Gross profit$90.6M+9.0%
Operating income$50.9M+4.3%
Net income-$83.4M-231%
EPS (diluted)-$1.14-248%

Balance sheet

See full
Cash & equivalents$570.4M+43.5%
Total debt$269.7M-40.2%
Total equity$1.2B
Total assets$1.7B+27.7%

Cash flow

See full
Operating cash flow$52.0M+17.9%
CapEx$429.0K
Free cash flow$51.5M+16.9%

Valuation

See full
Market cap$1.49B+20.6%
Enterprise value$1.19B-7.6%
P/E4.2×-27.8×
P/S3.4×+0.1×

Profitability

See full
Gross margin72.2%-10.9pp
Operating margin36.9%-10.7pp
Net margin81.2%+70.8pp
FCF margin43.1%-11.1pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio16×+13.4×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335235
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Purchases and sales of other investments managed by ISP Fund LP, net6,6658,086
Purchases of property and equipment(921)
Sale of property and equipment185
Net cash used in investing activities(18,256)(1,552)
Cash flows from financing activities
Repurchase of common stock(51,314)
Repurchase of shares to satisfy tax withholding(252)(91)
Proceeds from issuances of common stock, net2,0151,521

Item 1. Financial Statements

FAQ

What is Innoviva, Inc.'s investing cash flow?
Innoviva, Inc. (INVA) reported investing cash flow of -$55.26M in Q2 2026.
How has Innoviva, Inc.'s investing cash flow changed year-over-year?
Innoviva, Inc.'s investing cash flow decreased by 266.8% year-over-year, from $33.12M to -$55.26M.
What is the long-term trend for Innoviva, Inc.'s investing cash flow?
Over 2 years (2023 to 2025), Innoviva, Inc.'s investing cash flow has grown at a -22.1% compound annual growth rate (CAGR), from -$66.76M to $40.5M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Innoviva, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude